Tomonori Ishii

16PUBLICATIONS
60CO-AUTHORS
Regenerative medicine (incl. stem cells)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 27, 2026
Rapid versus conventional glucocorticoid tapering in pure membranous LN: a multicentre retrospective study.

|Jun 26, 2026
Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trial.

|Jan 29, 2026
Long-term safety and efficacy of tocilizumab in adult-onset Still's disease: open-label, long-term extension of the phase III trial.

Koji Suzuki, Hideto Kameda, Kei Ikeda

|Jun 14, 2025
Serum cytokine levels towards precision medicine in Still's disease: a subanalysis of a randomized controlled trial of tocilizumab.

Koji Suzuki, Hideto Kameda, Kei Ikeda

|May 19, 2025
Protocol: Filgotinib in addition to methotrexate versus filgotinib monotherapy in patients with rheumatoid arthritis with an inadequate response to methotrexate: A multicenter, prospective, open-label, randomized controlled trial (FAITHFUL Study).

Mitsuhiro Akiyama, Toshihiko Hidaka, Motohide Kaneko

|Mar 19, 2025
Phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study of ustekinumab in patients with Takayasu arteritis.

Hajime Yoshifuji, Tomonori Ishii, Hiroki Ohashi

Pageof 3

Frequent Collaborators

7 joint publications

Hiroko Sato

6 joint publications

Hiroshi Fujii

6 joint publications

Yoshiya Tanaka

5 joint publications

Tsuyoshi Shirai